Abstract: Coxsackievirus group B (CVB) is considered as one of the most common pathogens of human viral myocarditis. CVB-induced myocarditis is mainly characterized by the persistence of the virus infection and immune-mediated inflammatory injury. Costimulatory signals are crucial for the activation of adaptive immunity. Our data reveal that the CVB type 3 (CVB3) infection altered the expression profile of costimulatory molecules in host cells. CVB3 infection caused the decrease of PD-1 ligand expression, partially due to the cleavage of AU-rich element binding protein AUF1 by the viral protease 3Cpro, leading to the exacerbated inflammatory injury of the myocardium. Moreover, systemic PD-L1 treatment, which augmented the apoptosis of proliferating lymphocytes, alleviated myocardial inflammatory injury. Our findings suggest that PD1-pathway can be a potential immunologic therapeutic target for CVB-induced myocarditis.
Biography:
Ms Xueqing Wang is a PhD Candaidate from the School of Medical and Health Sciences at Edith Cowan University. Her PhD Project is ‘How Coxsackievirus B3 Infection Acts as a Risk Factor for Type 2 Diabetes Mellitus by Triggering Autophagy and Persistent Inflammation’. She has published 5 papers as the co-author in reputed journals and won the 2nd price in the australian academic transformation speech contest, Alpha Innovation Contest 2019.
Advanced Techniques in Clinical Microbiology received 110 citations as per Google Scholar report